The global epidemiology of nonalcoholic fatty liver disease... : Hepatology The global
epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) …

Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common liver
disease globally and is currently estimated to affect 38% of the global population. Only a …

Background & Aims Although hepatitis B and C have been the main drivers of hepatocellular
carcinoma (HCC), nonalcoholic steatohepatitis (NASH) has recently become an important …

OBJECTIVES: Chronic infection with hepatitis C virus (HCV) was previously the leading
indication for liver transplant (LT) in the United States. However, since 2014 the use of direct …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …

Nonalcoholic steatohepatitis (NASH) is emerging as a leading cause of chronic liver
disease. However, therapeutic options are limited by incomplete understanding of the …

Background Hepatocellular carcinoma (HCC) incidences have been increasing in the
United States. This study aimed to examine temporal trend of HCC survival and determine …

Objectives To determine the prevalence of nonalcoholic fatty liver disease (NAFLD) in
children with obesity because current estimates range from 1.7% to 85%. A second objective …

Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent, dynamic disease that occurs
across the age spectrum and can lead to cirrhosis and hepatocellular carcinoma. There are …

Cirrhosis is the common end stage of a number of chronic liver conditions and a significant
cause of morbidity and mortality. With the growing epidemic of obesity and metabolic …